PIEZO2 and neoplasm: It is possible that PIEZO2-mediated mechanotransduction could contribute to tumor cell survival under therapeutic stress, suggesting that combined therapies targeting PIEZO2 and other key signaling pathways may provide increased therapeutic benefits.